Bortezomib blocks the catabolic process of autophagy via a cathepsin-dependent mechanism, affects endoplasmic reticulum stress and induces caspase-dependent cell death in antiestrogen-sensitive and resistant ER+ breast cancer cells.

Source:http://linkedlifedata.com/resource/pubmed/id/20110775

Download in:

View as

General Info

PMID
20110775